1. Home
  2. PCVX vs OHI Comparison

PCVX vs OHI Comparison

Compare PCVX & OHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • OHI
  • Stock Information
  • Founded
  • PCVX 2013
  • OHI N/A
  • Country
  • PCVX United States
  • OHI United States
  • Employees
  • PCVX N/A
  • OHI N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • OHI Real Estate Investment Trusts
  • Sector
  • PCVX Health Care
  • OHI Real Estate
  • Exchange
  • PCVX Nasdaq
  • OHI Nasdaq
  • Market Cap
  • PCVX 4.4B
  • OHI 10.8B
  • IPO Year
  • PCVX 2020
  • OHI N/A
  • Fundamental
  • Price
  • PCVX $34.50
  • OHI $36.26
  • Analyst Decision
  • PCVX Strong Buy
  • OHI Buy
  • Analyst Count
  • PCVX 10
  • OHI 9
  • Target Price
  • PCVX $136.50
  • OHI $40.88
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • OHI 2.7M
  • Earning Date
  • PCVX 08-05-2025
  • OHI 07-31-2025
  • Dividend Yield
  • PCVX N/A
  • OHI 7.38%
  • EPS Growth
  • PCVX N/A
  • OHI 44.22
  • EPS
  • PCVX N/A
  • OHI 1.60
  • Revenue
  • PCVX N/A
  • OHI $1,084,876,000.00
  • Revenue This Year
  • PCVX N/A
  • OHI $12.23
  • Revenue Next Year
  • PCVX N/A
  • OHI $5.93
  • P/E Ratio
  • PCVX N/A
  • OHI $22.69
  • Revenue Growth
  • PCVX N/A
  • OHI 11.29
  • 52 Week Low
  • PCVX $27.66
  • OHI $33.43
  • 52 Week High
  • PCVX $121.06
  • OHI $44.42
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 53.91
  • OHI 42.19
  • Support Level
  • PCVX $31.79
  • OHI $36.20
  • Resistance Level
  • PCVX $34.63
  • OHI $37.01
  • Average True Range (ATR)
  • PCVX 1.38
  • OHI 0.52
  • MACD
  • PCVX 0.09
  • OHI -0.06
  • Stochastic Oscillator
  • PCVX 86.31
  • OHI 7.36

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About OHI Omega Healthcare Investors Inc.

Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).

Share on Social Networks: